Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS
CORDIScovery podcast 50th episode CORDIScovery podcast 50th episode
Contenuto archiviato il 2024-05-27

A cluster for tuberculosis vaccine development

Obiettivo

The overall objective of the Cluster is to establish a framework for preclinical development of novel tuberculosis vaccine candidates. We aim to identify optimal strategies for generation of vaccine candidates by comparing innovative approaches based on identification of novel protein antigens, characterisation of non-protein antigens that elicit T cell responses in man, and construction of live attenuated strains of mycobacteria. New vaccines will be compared alone or in combination in standardised experimental challenge models to identify candidates superior to the existing BCG vaccine. In parallel, the immunological mechanisms underlying vaccine-induced protection will be characterised in man and in experimental models. This information will be used to develop immunological tests for initial clinical assessment of new vaccines. Integration of these activites, with the participation of the top academic and industrial researchers in Europe (Aventis Pasteur, SmithKline Beecham and the Statens Serum Institut), is essential for completion of the final goal of bringing one or more new vaccines to a stage suitable for clinical trials.
Brief description
The workplan for the Cluster is based on five interactive component
Projects. Project 1 will focus on establishment of a standardised protocol
for preclinical assessment of vaccine candidates in a series of animal challenge models. Protein antigens with known vaccine potential will be used for comparative evaluation of delivery systems based on novel adjuvants, DNA constructs, and attenuated viral vectors. Candidates that perform optimally in naive challenge models in mice and guinea pigs will be taken forward into screening in bovine and primate models. Projects 2 and 3 are directed towards discovery of new vaccine candidates which will subsequently feed into the preclinical screening programme established in Project 1. Participants in Project 2 will use powerful new tools for genetic manipulation of mycobacteria to construct a new generation of live attenuated mycobacterial vaccines. These will include recombinant BCG strains optimised for immunogenicity and safety, as well as M. tuberculosis strains lacking key virulence determinants following random transposon mutagenesis or predictions from bioinformatic and comparative genomic analysis. Project 3 will focus on novel non-protein antigens from mycobacteria that have recently been demonstrated to induce human T cell responses. A key aspect of the Cluster is that each of these strategies can be pursued simultaneously and that the different classes of candidate can be directly compared against each other and in combination. Finally, participants in Project 4 will study the mechanisms underlying the pathological manifestations of tuberculosis and the protective immune responses induced by the different vaccine candidates. This will identify immunological tests suitable for initial assessment of new vaccines in clinical trials.

Campo scientifico (EuroSciVoc)

CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP. Cfr.: Il Vocabolario Scientifico Europeo.

È necessario effettuare l’accesso o registrarsi per utilizzare questa funzione

Programma(i)

Programmi di finanziamento pluriennali che definiscono le priorità dell’UE in materia di ricerca e innovazione.

Argomento(i)

Gli inviti a presentare proposte sono suddivisi per argomenti. Un argomento definisce un’area o un tema specifico per il quale i candidati possono presentare proposte. La descrizione di un argomento comprende il suo ambito specifico e l’impatto previsto del progetto finanziato.

Invito a presentare proposte

Procedura per invitare i candidati a presentare proposte di progetti, con l’obiettivo di ricevere finanziamenti dall’UE.

Dati non disponibili

Meccanismo di finanziamento

Meccanismo di finanziamento (o «Tipo di azione») all’interno di un programma con caratteristiche comuni. Specifica: l’ambito di ciò che viene finanziato; il tasso di rimborso; i criteri di valutazione specifici per qualificarsi per il finanziamento; l’uso di forme semplificate di costi come gli importi forfettari.

CSC - Cost-sharing contracts

Coordinatore

INSTITUT PASTEUR
Contributo UE
Nessun dato
Indirizzo
Rue du Docteur Roux 25
75724 PARIS
Francia

Mostra sulla mappa
Costo totale

I costi totali sostenuti dall’organizzazione per partecipare al progetto, compresi i costi diretti e indiretti. Questo importo è un sottoinsieme del bilancio complessivo del progetto.
Nessun dato

Partecipanti (29)

Condividi questa pagina Condividi questa pagina sui social network

Scarica Scarica il contenuto della pagina

Ultimo aggiornamento: 12 Aprile 2005

Il mio fascicolo

Permalink: https://cordis.europa.eu/project/id/QLK2-CT-1999-01093/it

European Union, 2026

Il mio fascicolo 0 0